Science Corporation promoted Darius Shahida from chief strategy officer to president, effective immediately. He reports to Max Hodak, the co-founder and chief executive.
The change lands while PRIMA moves from trial to commerce. The subretinal implant treats vision loss from geographic atrophy in age-related macular degeneration. It took a CE mark in July 2026 and is now being prescribed and implanted in Europe and the UK.
Science is based in Alameda, California, with an office in Paris. Naming a president usually marks the point where a neurotech company stops running as a research shop and starts answering to shipping schedules and audits.